Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
MRMD
$0.06
-2.63%
MRMD
· Marimed Inc.
Market Cap
$22.57M
Shares
403.04M
Volume · Oct 20
131.65K
Avg daily vol (3M)
561.09K
All webcasts
Earnings call · FY2023 Q3
Marimed Inc. (MRMD) Q3 2023 Earnings Call
Revenue
$38.80M
+14.4% YoY
Diluted EPS
-$0.01
-200% YoY
Gross margin
43.4%
-4.3 pp YoY
Net income
-$4.26M
-257.4% YoY
Forward guidance
4 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Nov 8, 2023.
| Metric | Period | Guided | Basis | Actual |
|---|---|---|---|---|
|
Revenue
full year 2023
|
$148M – $150M | — | $148.6M within | |
|
Gross margin
full year 2023
|
45% | Non-GAAP | — | |
|
Capital expenditures
Lowered
full year 2023
|
$22M – $25M | — | — | |
|
Non-GAAP Adjusted EBITDA
Lowered
full year 2023
|
$27M – $32M | Non-GAAP | — |
SEC filing · Item 2.02
8-K earnings release
Filed Nov 8, 2023 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 9, 2023 · complete as-filed document